BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

832 related articles for article (PubMed ID: 16911282)

  • 1. Acral lentiginous melanoma: a clinicoprognostic study of 126 cases.
    Phan A; Touzet S; Dalle S; Ronger-Savlé S; Balme B; Thomas L
    Br J Dermatol; 2006 Sep; 155(3):561-9. PubMed ID: 16911282
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Acral lentiginous melanoma: histopathological prognostic features of 121 cases.
    Phan A; Touzet S; Dalle S; Ronger-Savlé S; Balme B; Thomas L
    Br J Dermatol; 2007 Aug; 157(2):311-8. PubMed ID: 17596173
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of high molecular weight melanoma-associated antigen expression in primary acral lentiginous melanoma lesions with poor prognosis.
    Kageshita T; Kuriya N; Ono T; Horikoshi T; Takahashi M; Wong GY; Ferrone S
    Cancer Res; 1993 Jun; 53(12):2830-3. PubMed ID: 8504426
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Is head and neck melanoma a distinct entity? A clinical registry-based comparative study in 5702 patients with melanoma.
    Hoersch B; Leiter U; Garbe C
    Br J Dermatol; 2006 Oct; 155(4):771-7. PubMed ID: 16965427
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acral lentiginous melanoma: conventional histology vs. three-dimensional histology.
    Lichte V; Breuninger H; Metzler G; Haefner HM; Moehrle M
    Br J Dermatol; 2009 Mar; 160(3):591-9. PubMed ID: 19067697
    [TBL] [Abstract][Full Text] [Related]  

  • 6. "Gloves-and-socks" melanoma: does histology make a difference?
    Soudry E; Gutman H; Feinmesser M; Gutman R; Schachter J
    Dermatol Surg; 2008 Oct; 34(10):1372-8. PubMed ID: 18616532
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Management of primary cutaneous melanoma of the hands and feet: a clinicoprognostic study.
    Rex J; Paradelo C; Mangas C; Hilari JM; Fernández-Figueras MT; Ferrándiz C
    Dermatol Surg; 2009 Oct; 35(10):1505-13. PubMed ID: 19686364
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acral lentiginous melanoma presents distinct clinical profile with high cancer susceptibility.
    Nagore E; Pereda C; Botella-Estrada R; Requena C; Guillén C
    Cancer Causes Control; 2009 Feb; 20(1):115-9. PubMed ID: 18758972
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The prevalence of melanocytic nevi on the soles in the Japanese population.
    Kogushi-Nishi H; Kawasaki J; Kageshita T; Ishihara T; Ihn H
    J Am Acad Dermatol; 2009 May; 60(5):767-71. PubMed ID: 19389519
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biological behavior and natural course of acral malignant melanoma. Clinical and histologic features and prognosis of palmoplantar, subungual, and other acral malignant melanomas.
    Jimbow K; Takahashi H; Miura S; Ikeda S; Kukita A
    Am J Dermatopathol; 1984; 6 Suppl():43-53. PubMed ID: 6528942
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Subungual melanoma: a study of 124 cases highlighting features of early lesions, potential pitfalls in diagnosis, and guidelines for histologic reporting.
    Tan KB; Moncrieff M; Thompson JF; McCarthy SW; Shaw HM; Quinn MJ; Li LX; Crotty KA; Stretch JR; Scolyer RA
    Am J Surg Pathol; 2007 Dec; 31(12):1902-12. PubMed ID: 18043047
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Dubreuilh melanoma: and epidemiologic and prognostic study].
    Tournillac I; Picot MC; Dereure O; Guilhou JJ; Guillot B
    Ann Dermatol Venereol; 1999 Oct; 126(10):676-80. PubMed ID: 10604003
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic variables and prognostic groups for malignant melanoma. The information from Cox and Classification And Regression Trees analysis: an Italian population-based study.
    Crocetti E; Mangone L; Lo Scocco G; Carli P
    Melanoma Res; 2006 Oct; 16(5):429-33. PubMed ID: 17013092
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Factors associated with a high tumour thickness in patients with melanoma.
    Baumert J; Plewig G; Volkenandt M; Schmid-Wendtner MH
    Br J Dermatol; 2007 May; 156(5):938-44. PubMed ID: 17381454
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dermoscopic features of acral lentiginous melanoma in a large series of 110 cases in a white population.
    Phan A; Dalle S; Touzet S; Ronger-Savlé S; Balme B; Thomas L
    Br J Dermatol; 2010 Apr; 162(4):765-71. PubMed ID: 19922528
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acral Lentiginous Melanoma.
    Goydos JS; Shoen SL
    Cancer Treat Res; 2016; 167():321-9. PubMed ID: 26601870
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acral lentiginous melanoma: who benefits from sentinel lymph node biopsy?
    Ito T; Wada M; Nagae K; Nakano-Nakamura M; Nakahara T; Hagihara A; Furue M; Uchi H
    J Am Acad Dermatol; 2015 Jan; 72(1):71-7. PubMed ID: 25455840
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acral cutaneous melanoma in caucasians: clinical features, histopathology and prognosis in 112 patients.
    Kuchelmeister C; Schaumburg-Lever G; Garbe C
    Br J Dermatol; 2000 Aug; 143(2):275-80. PubMed ID: 10951133
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Thick melanoma: the problem continues.
    Tejera-Vaquerizo A; Mendiola-Fernández M; Fernández-Orland A; Herrera-Ceballos E
    J Eur Acad Dermatol Venereol; 2008 May; 22(5):575-9. PubMed ID: 18081751
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Acral lentiginous melanoma (ALM)--clinical features].
    Gartmann H
    Z Hautkr; 1982 Dec; 57(24):1777-81. PubMed ID: 7168225
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 42.